Collaboration - March 7, 2014
Sectra and IDS to collaborate in mammography
The two companies brings Sectra CloudFlex, a cloud-based, comprehensive suite of breast imaging tools designed for low-volume mammography sites. The tools’ modular functionality includes a clinical reporting platform, advanced speech recognition technology, a workflow portal and CRM system. This synergistic collaboration with IDS allows Sectra to expand its women’s health portfolio into small breast centers […]
Collaboration - February 12, 2014
New European program targets novel antibiotics
More than 30 European universities and companies are joining forces in a 6 year programme funded by the Innovative Medicines Initiative (IMI) to develop novel antibiotics. The initiative is led by GlaxoSmithKline and Uppsala University. The novel antibiotics are being developed against Gram-negative pathogens in a project called ENABLE (European Gram Negative Antibacterial Engine). The ENABLE […]
Collaboration - February 5, 2014
Life science companies form new network
Recipharm, Cobra Biologics and Syntagon team up with five other companies in a new network to undertake the distortion of competition on the market. The new initiative is called LSIS, Life Science Innovation Support, and is formed to assure fair competition between private and public players. The background to the new formation is according to a […]
Collaboration - February 5, 2014
Saromics and Bioversys tackle antimicrobial resistance
Swedish Saromics Biostructures join forces with Swiss Bioversys to fight against multidrug-resistant bacterial infections. The two companies will collaborate in an international project supported by the European initiative Eurostars. Saromics Biostructures and Bioversys will combine technology modules, expertise and resources to drive the drug development process of initial hit molecules towards fully characterized lead molecules that qualify […]
Collaboration - January 29, 2014
SARomics Biostructures and Xbrane Bioscience form a strategic partnership
The biotech companies SARomics Biostructures and Xbrane Bioscience have signed a strategic partnership for “off-the-shelf” protein structures. The two companies will combine their expertise within their respective fields to deliver “off-the-shelf” protein structure services. The “off-the-shelf” concept is a service product that simplifies and de-risks drug discovery activities. It is targeted towards structure-based design projects […]
Collaboration - January 27, 2014
Active Biotech and Teva remain committed to clinical development program for multiple sclerosis
Teva Pharmaceutical Industries and Active Biotech has announced that both companies remain committed to the NERVENTRA(laquinimod) clinical development program for multiple sclerosis (MS) following the announcement of a negative opinion for the treatment of relapsing-remitting multiple sclerosis (RRMS) by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). The […]
